Abstract | CONTEXT: OBJECTIVE: RESEARCH DESIGN AND METHODS: Clinical data were obtained from chart review. Gene sequencing was performed on genomic DNA. RESULTS: CONCLUSIONS: The first two cases demonstrate that mutations in HNF1A ( MODY3) can cause hyperinsulinism early in life and diabetes later, similar to the phenotype recently reported for HNF4A ( MODY1) mutations. Case 3 indicates that the effects of HNF4A mutations in infancy may extend beyond pancreatic β-cells to produce a disorder similar to glucose transporter 2 deficiency involving both liver glycogen metabolism and renal tubular transport.
|
Authors | Diana E Stanescu, Nkecha Hughes, Bernard Kaplan, Charles A Stanley, Diva D De León |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 97
Issue 10
Pg. E2026-30
(Oct 2012)
ISSN: 1945-7197 [Electronic] United States |
PMID | 22802087
(Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- HNF1A protein, human
- HNF4A protein, human
- Hepatocyte Nuclear Factor 1-alpha
- Hepatocyte Nuclear Factor 4
|
Topics |
- Age of Onset
- Child
- Child, Preschool
- Congenital Hyperinsulinism
(genetics)
- Diabetes Mellitus, Type 2
(genetics)
- Female
- Hepatocyte Nuclear Factor 1-alpha
(genetics)
- Hepatocyte Nuclear Factor 4
(genetics)
- Humans
- Hypoglycemia
(genetics)
- Mutation, Missense
- Phenotype
|